InvestorsHub Logo
Followers 1
Posts 45
Boards Moderated 0
Alias Born 01/25/2016

Re: None

Monday, 08/13/2018 12:23:01 PM

Monday, August 13, 2018 12:23:01 PM

Post# of 513
SBOT has about 5 million shares issued and $11 million cash on the books June 30th. Read the investor slides on their website. With more than $2 per share cash and trading under $1.50 I would expect the competition to buy them out. Reduce staff (cut overhead) and get their incredible technology for free. I'm a buyer here. A couple of drugs they support are in phase III trials. The Lupus drug looks very positive. KLH molecule used in a lot of drugs being tested. Looks like some very positive results to date. Downside risk from here seems very low. Upside opportunity looks extreme. Do some due diligence and I think you will be interested.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EDSA News